StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2023 - 03 - 07
6
2022 - 12 - 12
7
2022 - 12 - 08
6
2022 - 11 - 10
7
2022 - 11 - 03
13
2022 - 10 - 26
8
2022 - 10 - 17
5
2022 - 07 - 12
5
2022 - 06 - 06
5
2022 - 05 - 26
10
2022 - 04 - 28
5
2022 - 04 - 13
5
2022 - 04 - 12
5
2022 - 04 - 11
6
2022 - 04 - 04
5
2022 - 03 - 31
5
2022 - 03 - 09
5
2022 - 03 - 08
6
2022 - 03 - 01
5
2022 - 01 - 26
5
2022 - 01 - 24
5
2022 - 01 - 12
5
2022 - 01 - 06
6
2022 - 01 - 05
7
2021 - 12 - 16
7
2021 - 12 - 14
6
2021 - 12 - 13
12
2021 - 12 - 12
5
2021 - 12 - 09
6
2021 - 12 - 06
8
2021 - 11 - 30
5
2021 - 11 - 29
6
2021 - 11 - 12
9
2021 - 11 - 09
6
2021 - 11 - 08
7
2021 - 11 - 04
6
2021 - 10 - 27
7
2021 - 10 - 25
7
2021 - 10 - 07
7
2021 - 09 - 29
6
2021 - 09 - 28
5
2021 - 09 - 23
5
2021 - 09 - 16
5
2021 - 09 - 15
6
2021 - 09 - 13
6
2021 - 09 - 09
6
2021 - 09 - 08
8
2021 - 08 - 10
5
2021 - 07 - 15
7
2021 - 07 - 09
7
2021 - 06 - 28
7
2021 - 06 - 24
7
2021 - 06 - 23
11
2021 - 06 - 16
6
2021 - 06 - 11
8
2021 - 06 - 04
9
2021 - 05 - 19
7
2021 - 04 - 12
5
2021 - 03 - 02
5
2020 - 12 - 07
6
Sector
Health services
1
Health technology
6
Manufacturing
1
Tags
5g
6
Acquisition
7
Alliances
5
Announces collaboration
3
Approval
6
Awards
4
Bb-301
3
Biopharma
11
Bioscience
6
Biotech
4
Biotech-beach
7
Brands
3
Cancer
7
Ceo
3
China
3
Chip
3
Collaboration
9
Commercialization
4
Conference
91
Contract
5
Covid
10
Covid-19
6
Designation
4
Disease
4
Drug
3
Earnings
4
Energy
11
Enroll
3
Europe
3
Events
12
Financial results
15
Food
7
Grant
6
Granted
6
Growth
18
Iot
8
Media
4
Money
5
N/a
413
Offering
12
Partnership
4
People
10
Pharm-country
5
Pharma
4
Phase 1
8
Phase 1b
5
Phase 2
7
Phase 2b
5
Positive
5
Presentation
13
Research
24
Results
26
Sales
7
Software
7
Technology
15
Test
7
Therapeutics
6
Therapy
6
Treatment
9
Trial
20
Entities
Benitec biopharma inc.
2
Cardiff oncology, inc.
1
Hoth therapeutics, inc.
1
India globalization capital inc.
1
Longboard pharmaceuticals inc
1
Novavax, inc.
1
Xbiotech inc.
1
Symbols
BNTC
2
CRDF
1
HOTH
1
IGC
1
LBPH
1
NVAX
1
XBIT
1
Exchanges
Amex
1
Nasdaq
7
Crawled Date
2021 - 09 - 08
8
Crawled Time
12:00
4
13:00
1
14:00
2
21:00
1
Source
ir.benitec.com
2
ir.hoththerapeutics.com
1
www.biospace.com
4
www.igcinc.us
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 09 - 08
tags :
Phase 1
save search
Cardiff Oncology Announces New Data from Phase 1b/2 Trial in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival
Published:
2021-09-08
(Crawled : 21:00)
- biospace.com/
CRDF
|
$4.18
0.24%
-0.24%
300K
|
Health Services
|
-43.44%
|
O:
0.0%
H:
1.49%
C:
-4.6%
phase 1
cancer
colorectal cancer
trial
phase 1b
phase 2b
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
Published:
2021-09-08
(Crawled : 14:00)
- igcinc.us
IGC
4
|
$0.439
-3.86%
-5.15%
430K
|
Health Technology
|
-72.33%
|
O:
6.92%
H:
1.76%
C:
-7.06%
alzheimer
phase 1
trial
phase 2
phase 3
alzheimer’s
alzheimer's
Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic Cancer
Published:
2021-09-08
(Crawled : 14:00)
- biospace.com/
XBIT
|
$8.07
-1.35%
-1.3%
67K
|
Health Technology
|
-48.63%
|
O:
0.25%
H:
0.89%
C:
-0.44%
phase 1
therapy
cancer
biotech
iot
pancreatic
phase 2
phase 3
pancreas
Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza
Published:
2021-09-08
(Crawled : 13:00)
- biospace.com/
NVAX
|
$4.15
-0.96%
-0.96%
2M
|
Health Technology
|
-98.47%
|
O:
0.92%
H:
1.74%
C:
-2.29%
covid
phase 1
vaccine
influenza
trial
phase 2
phase 3
covid-19
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
Published:
2021-09-08
(Crawled : 12:00)
- ir.benitec.com
BNTC
|
$6.72
-2.04%
-1.63%
67K
|
Health Technology
|
71.87%
|
O:
-1.53%
H:
2.34%
C:
-1.82%
bb-301
biopharma
phase 1
positive
trial
phase 1b
phase 2b
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
Published:
2021-09-08
(Crawled : 12:00)
- ir.benitec.com
BNTC
|
$6.72
-2.04%
-1.63%
67K
|
Health Technology
|
71.87%
|
O:
-1.53%
H:
2.34%
C:
-1.82%
bb-301
biopharma
phase 1
trial
phase 1b
phase 2b
designation
Hoth Therapeutics Announces Positive Phase 1b Results for Completed First Cohort of Patient Trial of BioLexa
Published:
2021-09-08
(Crawled : 12:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
-1.68%
1.2%
17K
|
Health Technology
|
-12.69%
|
O:
-1.49%
H:
1.52%
C:
1.52%
phase 1
positive
results
trial
phase 1b
phase 2b
Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial
Published:
2021-09-08
(Crawled : 12:00)
- biospace.com/
LBPH
|
$19.75
-2.57%
-2.58%
300K
|
Manufacturing
|
90.82%
|
O:
-0.58%
H:
1.75%
C:
1.55%
phase 1
trial
phase 1b
phase 2b
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.